- About Us
- News & Events
- Get Information
- Our Research
- Treatment Trials
Memantine for CTD/BPD
Understanding Complex Trauma Disorder (also known as Borderline Personality Disorder) and the Role of Memantine
Aims: To analyse the relationship between early life traumatic events and the expression of Complex Trauma Disorder (also known as Borderline Personality Disorder). The second part of the study aims to examine the efficacy of a cognitive enhancing agent, memantine, in improving symptoms of borderline personality disorder.
Participants: Women and men aged 18-65 with symptoms consistent with Complex Trauma Disorder.
Method: Participants will complete screening questionnaires that include a diagnostic test and questions regarding early trauma experience. Participants may then choose to enter an 8-week randomised control trial in which they will be assigned to take either 1) memantine 10<20mg/day or 2) placebo. Researchers will meet with participants fortnightly to monitor their progress (some of these visits can be done over the phone).
Project status: Currently recruiting
Researchers: Professor Jayashri Kulkarni, Dr Caroline Gurvich, Ms Emmy Gavridilis, Dr Jasmin Grigg, Dr Natalie Thomas, Ms Amelia Arnold
Contact information: For more information, please contact Amelia Arnold via email firstname.lastname@example.org or phone (03) 9076 6589
1. How To Treat: Borderline Personality Disorder (Australian Doctor). This article was originally published by Australian Doctor. To see other articles like this click here.
|How to Treat BPD Aus Doc.pdf||634.27 KB|